This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Ohr Pharmaceuticals, Inc. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: The Innovations of Eric Chellquist
Introduction
Eric Chellquist is an accomplished inventor based in Plymouth Meeting, PA. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on squalamine dilactate. His research focuses on the therapeutic applications of this compound, which has implications for treating various medical conditions.
Latest Patents
Eric Chellquist holds a patent for "Polymorphic and amorphous salt forms of squalamine dilactate." This invention relates to the selection of squalamine salts, methods of their synthesis, and their therapeutic uses. The patent highlights the advantages of these salts in terms of manufacturing, product stability, and toxicity. Specifically, it addresses various forms of the dilactate salt of squalamine and their utility in inhibiting neovascularization and endothelial cell proliferation.
Career Highlights
Throughout his career, Eric has worked with notable companies in the pharmaceutical industry, including Ohr Pharmaceuticals, Inc. and Enterin, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Eric has collaborated with several professionals in his field, including Mary Doubleday and Charles Gilbert. These partnerships have played a crucial role in the development of his inventions and the successful application of his research.
Conclusion
Eric Chellquist's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions, particularly in the area of squalamine dilactate, demonstrate the potential for new treatments that can improve patient outcomes.